294 related articles for article (PubMed ID: 30105847)
21. Topical metformin in the treatment of melasma: A preliminary clinical trial.
Banavase Channakeshavaiah R; Andanooru Chandrappa NK
J Cosmet Dermatol; 2020 May; 19(5):1161-1164. PubMed ID: 31502392
[TBL] [Abstract][Full Text] [Related]
22. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
Rendon MI; Barkovic S
J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
[TBL] [Abstract][Full Text] [Related]
23. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial.
Yasnova N; Sirait SP; Rahmayunita G
Acta Dermatovenerol Alp Pannonica Adriat; 2024 Jun; 33(2):83-88. PubMed ID: 38918942
[TBL] [Abstract][Full Text] [Related]
25. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study.
Yousefi A; Khani Khoozani Z; Zakerzadeh Forooshani S; Omrani N; Moini AM; Eskandari Y
Dermatol Surg; 2014 Jan; 40(1):33-7. PubMed ID: 24237751
[TBL] [Abstract][Full Text] [Related]
26. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
[TBL] [Abstract][Full Text] [Related]
29. Split-face comparison of hydroquinone 4% plus nitrogen plasma vs. hydroquinone 4% alone in the treatment of melasma.
Yousefi M; Hadian K; Babossalam S; Diab R; Akhlaghi M; Aghighi M; Abdollahimajd F; Shokri B
Lasers Med Sci; 2023 Apr; 38(1):113. PubMed ID: 37103690
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
[TBL] [Abstract][Full Text] [Related]
31. Pigmentation control in pregnancy-induced melasma: Clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum.
Makino ET; Jiang LI; Stephens TJ; Mikati M; Mehta RC
J Cosmet Dermatol; 2022 Nov; 21(11):5739-5746. PubMed ID: 35708506
[TBL] [Abstract][Full Text] [Related]
32. Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma.
Eshghi G; Khezrian L; Esna Ashari F
Acta Med Iran; 2016 Jan; 54(1):67-71. PubMed ID: 26853293
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
Nanda S; Grover C; Reddy BS
Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
[TBL] [Abstract][Full Text] [Related]
35. Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study.
Akl EM
J Dermatolog Treat; 2022 Jun; 33(4):2008-2013. PubMed ID: 33823725
[TBL] [Abstract][Full Text] [Related]
36. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
Pratchyapurit WO
J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
[TBL] [Abstract][Full Text] [Related]
37. Topical tranexamic acid as a promising treatment for melasma.
Ebrahimi B; Naeini FF
J Res Med Sci; 2014 Aug; 19(8):753-7. PubMed ID: 25422661
[TBL] [Abstract][Full Text] [Related]
38. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
Saki N; Darayesh M; Heiran A
J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
[TBL] [Abstract][Full Text] [Related]
39. Different therapeutic modalities for treatment of melasma.
Azzam OA; Leheta TM; Nagui NA; Shaarawy E; Hay RM; Hilal RF
J Cosmet Dermatol; 2009 Dec; 8(4):275-81. PubMed ID: 19958431
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
